Steer Health
AI-powered growth and automation platform for healthcare organizations covering patient acquisition, engagement, and operations.
Website: https://steerhealth.io/
Cover Block
Public sources
| Field | Value |
|---|---|
| Company | Steer Health |
| Tagline | AI-powered growth and automation platform for healthcare organizations covering patient acquisition, engagement, and operations |
| Headquarters | Dallas-Fort Worth, United States [Wellfound] |
| Founded | 2021 [Wellfound] |
| Stage | Seed [Wellfound] |
| Business model | SaaS |
| Industry | Healthtech |
| Technology | AI / Machine Learning |
| Geography | North America |
| Growth profile | Venture Scale |
| Founding team | Solo Founder |
| Founder | Sridhar Yerramreddy [Forbes Technology Council] |
| Funding label | Seed [Wellfound] |
| Total disclosed funding | $6,500,000 [Wellfound] |
Links
Public sources
- Website: https://steerhealth.io/
- LinkedIn: https://www.linkedin.com/company/steerhealth
Executive Summary
PUBLIC Steer Health sells an AI-based software platform for healthcare providers that sits across patient acquisition, access, engagement, and selected operational workflows, and it merits attention now because it has assembled an unusually broad front-door-to-back-office product story for a company that has disclosed only a Seed round [Steer Health] [Wellfound] [Crunchbase]. Founded in 2021 in the Dallas-Fort Worth area by Sridhar Yerramreddy, the company frames its origin around healthcare operators' day-to-day administrative burden, while outside publisher profiles and author pages consistently identify Yerramreddy as founder and CEO [Forbes Technology Council] [Dataversity, September 2025] [Forbes, 2024]. The product surface appears to center on Luna AI for voice and outreach, alongside modules such as SteerNotes, FastTrackCare, and revenue-cycle tooling, with the differentiation resting less on a single point product than on the claim that Steer connects marketing, access, clinical, and financial workflows in one system [Steer Health] [steerhealth.io] [AOL, June 2026].
The public traction picture is directionally interesting but still company-led: Steer and its recruiting materials claim support for 109 organizations, 472 locations, 45-plus hospitals, and more than 19 million patient lives, while its 2024 impact report says Luna AI handled 9.6 million patient queries and saved 9,257 clinician hours in Q4 2024 alone [Steer Health] [Wellfound]. Those figures suggest meaningful deployment breadth if they hold up in diligence, but the key analytical point is that the available evidence does not yet provide independent customer-level verification or contract detail. On team quality, the file is narrow but relevant: Yerramreddy is the only consistently verified founder in the source set, and public bylines indicate an ongoing focus on healthcare AI, workflow automation, and patient experience rather than a purely technical model-layer pitch [Forbes Technology Council] [Forbes, 2026] [Dataversity, September 2025].
On capitalization, public sources support one disclosed financing, a $6.5 million Seed round in February 2022, with investor identities not established in the available materials; the business model is SaaS, selling into hospitals, health systems, physician groups, and specialty practices [Wellfound] [Crunchbase]. The most visible recent third-party signal is Steer's reported June 2026 Hearst Health Prize win, which adds reputational weight but does not substitute for hard operating disclosure [AOL, June 2026] [StreetInsider, 2026]. Over the next 12 to 18 months, the central watchpoints are whether Steer can convert broad platform claims into independently verifiable reference accounts, sustain deployment growth beyond company-reported metrics, and show that its multi-workflow architecture translates into durable budget ownership inside provider organizations [Steer Health] [Wellfound] [Crunchbase].
Company-stated, unverified -- This section relies materially on company statements and Wellfound profile data, with partial corroboration from Crunchbase, Forbes contributor profiles, Dataversity, and AOL.
Taxonomy Snapshot
| Axis | Value |
|---|---|
| Stage | Seed |
| Business Model | SaaS |
| Industry / Vertical | Healthtech |
| Technology Type | AI / Machine Learning |
| Geography | North America |
| Growth Profile | Venture Scale |
| Founding Team | Solo Founder |
| Funding | $6,500,000 disclosed Seed funding |
How the Company Got Here
PUBLIC
Steer Health is a Dallas-Fort Worth healthtech startup founded in 2021 by Sridhar Yerramreddy, according to the company website and Crunchbase [steerhealth.io] [Crunchbase]. The company presents itself in plain terms as an AI patient access and growth platform for healthcare organizations, with a product scope that sits across patient acquisition, booking, referrals, and related operational workflows [steerhealth.io].
The chronology is still fairly compact in public records. Crunchbase lists the company as founded in 2021 and based in the Dallas-Fort Worth area [Crunchbase], while the company site identifies Yerramreddy as founder and CEO and frames the business around reducing administrative load in healthcare access and operations [steerhealth.io]. The first disclosed financing appears to be a $6.5 million Seed round in February 2022, as reflected in Crunchbase [Crunchbase]. More recently, Steer Health said it won the Hearst Health Prize in 2026, a milestone that at minimum indicates some external visibility beyond startup databases and the company blog [steerhealth.io].
Lightly corroborated -- Core company facts are corroborated by Crunchbase and the company website, but milestone detail in this section relies partly on company disclosures.
Product and Technology
MIXED
Steer Health is selling a broad patient access and operations layer rather than a single point tool. Public product descriptions center on Luna AI, an AI voice and outreach product that the company says captures missed calls, bookings, and referrals and writes back to the electronic health record, alongside workflow coverage for scheduling, reminders, referral intake, insurance questions, care gap outreach, patient reactivation, and balance recovery [steerhealth.io] [Steer Health] [steerhealth.io, 2024]. The company also presents adjacent modules including SteerNotes for clinical documentation, FastTrackCare for digital front door and patient access, and revenue cycle intelligence tooling aimed at reducing leakage and improving collections, with positioning that links marketing, access, clinical, and financial workflows in one platform [steerhealth.io] [Steer Health] [Dataversity, September 2025].
What stands out is the attempt to collapse front-office demand capture and back-end workflow completion into one conversational interface. That is an interesting product thesis in healthcare, where point solutions often stop at intake or messaging, but most of the evidence here still comes from company materials rather than third-party technical validation [steerhealth.io] [Steer Health] [AOL, June 2026]. The public record does support some operational scale claims tied specifically to Luna AI, with Steer reporting 9.6 million patient queries handled and 9,257 clinician hours saved in Q4 2024, though those figures appear in a company impact report and should be treated as management-reported outcomes rather than independently audited performance [steerhealth.io, 2024].
A few implementation clues are visible even without a verified product demo. Steer says Luna AI integrates with major EHRs and describes an "AI workforce" that can answer inquiries across channels, verify coverage, qualify patients, and book appointments in the same interaction, which suggests a workflow orchestration layer sitting on top of healthcare system integrations rather than a standalone chatbot [steerhealth.io] [steerhealth.io, Unknown]. The hiring mix, which includes senior backend engineering and healthcare implementation roles, is also consistent with an integration-heavy enterprise SaaS product, though any deeper view of the underlying stack would be an inference from job postings rather than confirmed architecture [Wellfound].
Company-stated, unverified -- This section relies primarily on company website statements and a company impact report, with limited third-party corroboration from founder profiles and syndicated coverage.
Where the Demand Sits
PUBLIC
Healthcare operators are spending against a stubborn throughput problem, and that is the market context that makes Steer Health legible now: the company is selling into the gap between patient demand and the administrative capacity to convert that demand into booked, completed, and paid encounters [steerhealth.io] [AOL, June 2026].
The available source set does not include a cited third-party TAM, SAM, or SOM for Steer Health’s exact category, so the market has to be framed through adjacent demand pools rather than a direct sizing model. Public materials position Steer across patient acquisition, patient access, engagement, clinical workflow, and revenue operations, with product surfaces spanning autonomous voice, digital front door tooling, clinical documentation, and revenue cycle intelligence [steerhealth.io] [Dataversity, September 2025]. That matters because Steer is not aiming at a single software budget line. According to its own product language, the wedge is the operational chain from first patient inquiry through scheduling, documentation, and collections, which places it in the overlap of patient access software, conversational AI, ambient or AI-assisted documentation, and revenue cycle tooling [steerhealth.io].
A practical read is that demand should be tied less to greenfield AI experimentation and more to labor substitution and revenue capture. Founder-authored and company materials repeatedly describe missed calls, referral leakage, scheduling friction, and front-office workload as the core pain points, while the 2024 impact report presents Luna AI as handling 9.6 million patient queries and saving 9,257 clinician hours in Q4 2024, figures that are company-reported rather than independently audited [steerhealth.io]. Even with that caveat, the direction of demand is credible: providers have an economic reason to pay for software that can capture after-hours demand, reduce unanswered inbound volume, and automate repetitive access workflows if integrations actually hold up in production [Forbes, 2026] [steerhealth.io].
The adjacent markets are large enough to matter, even if the boundaries are blurred. On one side sit patient access and digital front door vendors that focus on intake, search, online booking, reminders, and referral routing. On another sit AI voice and conversational automation providers that aim to deflect call-center volume and handle routine scheduling or service requests. A third substitute set includes clinical documentation and ambient note tools, where SteerNotes would compete for a different buyer and budget owner than Luna AI [steerhealth.io] [Dataversity, September 2025]. That mix creates upside if Steer can sell a platform story, but it also means the company is exposed to multiple buying committees and longer proof requirements than a single-point tool would face.
Macro and regulatory forces point in both directions. The tailwind is straightforward: provider organizations remain under pressure to do more with constrained staffing, and the founder’s published commentary argues that poorly integrated point solutions can worsen capital efficiency, which is consistent with buyer interest in fewer systems that span workflow boundaries [Forbes Councils, August 2026]. The counterweight is equally clear. In healthcare, any product that touches scheduling, triage, documentation, billing, or patient communication has to fit into existing EHR and operational environments, and public claims about writing back to the EHR or automating service workflows raise the implementation bar even when they also strengthen the product thesis [steerhealth.io]. The market opportunity is real, but it is not frictionless.
| Market lens | What the sources support | Source basis |
|---|---|---|
| Core category | AI-powered patient access and growth platform for healthcare organizations | [steerhealth.io] |
| Functional scope | Patient acquisition, access, engagement, clinical workflows, and revenue operations | [Dataversity, September 2025] [steerhealth.io] |
| Adjacent markets | Digital front door, conversational AI, clinical documentation, revenue cycle tools | [steerhealth.io] |
| Primary demand signal | Need to reduce missed calls, booking leakage, and administrative workload | [steerhealth.io] [Forbes, 2026] |
| Market proof cited by company | 9.6 million patient queries and 9,257 clinician hours saved in Q4 2024 | [steerhealth.io] |
The table shows a market thesis built from workflow adjacency rather than a clean analyst-defined category. That can support a broader budget conversation, but it also makes independent market sizing and apples-to-apples benchmarking harder from public evidence alone.
Company-stated, unverified -- This section relies materially on company materials and founder-authored sources, with no cited third-party market sizing report in the available evidence.
Competitive Landscape
MIXED
Steer Health is positioned less as a single-point healthcare AI tool and more as a workflow layer that tries to tie together patient acquisition, access, engagement, clinical documentation, and revenue operations, which places it against several different categories rather than one clean competitor set [steerhealth.io] [Wellfound].
That breadth matters because the practical alternatives are fragmented. On one side are incumbent systems of record, especially EHR-linked scheduling and patient-service workflows, which Steer says Luna AI can integrate with in order to handle booking and service interactions through a conversational interface [steerhealth.io]. On another are focused automation vendors aimed at a narrower bottleneck, such as digital front door, voice agents, clinical documentation, or revenue-cycle tools, while a third bucket is internal operator workarounds, call centers, and outsourced patient-access teams that remain the default substitute in many care settings [steerhealth.io/about.html]. The company is therefore competing against existing workflow inertia as much as against a named software peer.
The edge visible in public materials is functional scope tied to healthcare-specific workflow claims. Steer presents a product suite that includes Luna AI for voice and outreach, SteerNotes for AI clinical documentation, FastTrackCare for patient-access tooling, and Revenue Cycle Intelligence for collections and leakage reduction, all under a single platform thesis [steerhealth.io] [Steer Health, 2024]. If that stack is genuinely deployed across the footprint the company cites, 109 organizations, 472 locations, and 45-plus hospitals according to company and Wellfound materials, the advantage would come from embedded workflow data and cross-module distribution rather than from the model layer alone [Wellfound] [steerhealth.io]. The durability of that edge is still hard to call from public evidence, because the cited scale metrics are company-supplied and not independently audited.
The main exposure is the same breadth that makes the story interesting. A company selling across patient access, engagement, documentation, and revenue operations risks meeting more specialized competitors in each buying center, while incumbents retain control of core clinical and scheduling systems [steerhealth.io] [steerhealth.io/clinical/]. Steer also does not appear, from the sources reviewed, to own a proprietary channel akin to an EHR marketplace monopoly or a publicly documented captive distribution partner, which means its go-to-market position could be perishable if larger platforms narrow feature gaps or if buyers decide to standardize on fewer vendors [Crunchbase] [LinkedIn].
The most plausible 18-month scenario is continued share capture in provider groups and hospital operators that want one vendor to automate front-office demand capture and patient-service workflows before making a larger core-IT change. In that scenario, Steer Health is the likely winner if healthcare buyers keep prioritizing measurable operational relief over best-of-breed point solutions, because its public positioning is built around reducing missed calls, converting bookings, and automating service tasks tied to revenue outcomes [steerhealth.io] [Forbes Councils, August 2026]. The likelier loser under the opposite condition is a broad but lightly embedded platform narrative, including Steer itself, if procurement shifts back toward incumbent modules or if buyers insist on deeper proof by workflow and customer cohort than the current public record provides [AOL, June 2026] [Steer Health, 2024].
Opportunity
Upside case
PUBLIC The prize here is straightforward: if Steer Health can become the operating layer that sits between patient demand, front-office workflows, clinical documentation, and collections, it has a path to matter well beyond a point solution in patient engagement [steerhealth.io] [Wellfound].
The headline opportunity is not simply selling an AI receptionist to clinics. It is building a healthcare workflow platform that starts at patient acquisition and access, then extends into documentation and revenue capture, which is where budgets are larger and switching costs can rise over time [steerhealth.io] [steerhealth.io/about.html]. The public evidence is still company-led, so caution is warranted, but the product surface is broad enough to support that ambition: Steer describes Luna AI for voice and outreach, SteerNotes for clinical documentation, FastTrackCare for patient access, and revenue cycle tooling aimed at leakage reduction and collections improvement [steerhealth.io] [Steer Health, 2024]. If those modules work together inside existing EHR-driven workflows, the company could move from being purchased by a department to being budgeted as cross-functional infrastructure.
That outcome is at least reachable on the current record because the platform appears to be sold into real healthcare operators rather than a hypothetical future buyer. Steer and Wellfound both state that the platform supports 109 organizations, 472 locations, and 45 or more hospitals, while the company also claims coverage of 19 million patient lives [steerhealth.io] [Wellfound]. Those figures are unverified outside company-adjacent channels, but they point to a footprint that is already multi-site and multi-facility, which matters more here than raw logo count. The June 2026 Hearst Health Prize adds a modest external signal that the company has crossed into broader category visibility, even if the published coverage does not independently audit performance metrics [AOL, June 2026] [StreetInsider].
The paths to scale are easier to think about as discrete scenarios rather than a single linear plan.
| Scenario | What happens | Catalyst | Why it's plausible |
|---|---|---|---|
| Multi-module health system standard | Steer lands on patient access, then expands into documentation and revenue workflows across the same provider base | Cross-selling from Luna AI into SteerNotes and revenue cycle products | The company already presents these as a connected platform rather than separate apps, and says the system spans marketing, access, clinical, and financial pathways [steerhealth.io] [Steer Health, 2024] |
| EHR-adjacent automation layer for mid-market providers | Steer becomes the preferred automation stack for practices that want conversational scheduling, intake, and follow-up without large implementation work | Marketplace and integration-led adoption, including athenahealth-oriented packaging | Steer states that Luna AI integrates with major EHRs and advertises SMB-friendly pricing with no implementation fees for athenahealth marketplace customers [steerhealth.io] |
| Always-on patient engagement network | Steer turns high-volume patient interactions into a durable engagement engine that providers use for reactivation, reminders, balances, and referrals | Proof that one workflow, such as missed-call recovery or after-hours scheduling, reliably lifts booked visits and downstream collections | The company says Luna AI handles booking, rescheduling, referral intake, reminders, care-gap outreach, patient reactivation, and balance recovery, suggesting a broad set of repeat touchpoints once deployed [steerhealth.io] [Steer Health, 2024] |
The compounding logic is fairly clear if the product works as described. A provider can start with one painful workflow, usually missed calls or scheduling friction, then add adjacent automations once Steer is already tied into the EHR and patient communication flows [steerhealth.io]. Each added workflow should generate more interaction data, more operational dependence, and a stronger case for centralizing outreach, access, documentation, and payment recovery in one system. The company's own 2024 impact report claims Luna AI handled 9.6 million patient queries and saved 9,257 clinician hours in Q4 2024, which, if directionally accurate, suggests the beginnings of a scale flywheel where usage volume improves product relevance and makes replacement more disruptive for the customer [Steer Health, 2024].
The size of the win depends on whether Steer matures into infrastructure or remains an application vendor. Public sources provided here do not establish a clean public-market comparable or a third-party TAM figure, so any valuation framing has to stay conditional. On the current evidence, the more defensible upside framing is this: if the company turns a claimed footprint of 109 organizations and 472 locations into a durable multi-product install base, and if the award recognition in 2026 marks the start of broader enterprise credibility rather than a one-off signal, Steer could plausibly become a meaningful healthcare workflow platform with strategic value to larger health IT buyers or late-stage investors (scenario, not a forecast) [Wellfound] [AOL, June 2026]. The upside case rests less on a single AI feature than on owning a larger share of the patient-to-payment workflow inside provider organizations.
Company-stated, unverified -- This section relies heavily on company materials and Wellfound claims, with limited independent corroboration beyond award coverage from AOL and StreetInsider.
Sources
Public sources
[Wellfound] Steer Health | Wellfound | https://wellfound.com/company/steer-health
[Forbes Technology Council] Sridhar Yerramreddy - Forbes Technology Council | https://www.forbes.com/councils/forbestechcouncil/people/sridharyerramreddy/
[Steer Health] AI Patient Access and Growth Platform | Steer Health | https://steerhealth.io/
[Crunchbase] Steer Health - Crunchbase Company Profile & Funding | https://www.crunchbase.com/organization/steer-health
[Dataversity, September 2025] Author page: Sridhar Yerramreddy | https://www.dataversity.net/author/sridhar-yerramreddy/
[Forbes, 2024] Council Post: Prioritizing Convenience For Patients: Seamlessly Integrating On-Demand And Traditional Care | https://www.forbes.com/councils/forbestechcouncil/2024/09/03/prioritizing-convenience-for-patients-seamlessly-integrating-on-demand-and-traditional-care/
[AOL, June 2026] Steer Health Wins 2026 Hearst Health Prize | https://www.aol.com/articles/steer-health-wins-2026-hearst-224900000.html
[StreetInsider, 2026] Steer Health Awarded 2026 Hearst Health Prize | https://www.streetinsider.com/Press+Releases/Steer+Health+Awarded+2026+Hearst+Health+Prize/24827331.html
[Forbes, 2026] Council Post: Speech Is The New UX In Healthcare | https://www.forbes.com/councils/forbestechcouncil/2026/05/13/speech-is-the-new-ux-in-healthcare/
[steerhealth.io, 2024] IMPACT REPORT 2024 STEER HEALTH | https://go.steerhealth.io/hubfs/Steer%20Health%20Year%20End%20Report%202024-1.pdf
[steerhealth.io] About Us | Steer Health | https://steerhealth.io/about.html
[steerhealth.io] Clinical | Steer Health | https://steerhealth.io/clinical/
Articles about Steer Health
- Steer Health Wins the Hearst Health Prize for Agentic AI in Healthcare — The Dallas startup's platform, which recently won a major industry award, aims to automate patient access from first contact to booked appointment.